PaceMate Acquires Medtronic’s Paceart Optima Cardiac Workflow Solution

PaceMate, a company focused on cardiac data management and remote monitoring, has acquired Medtronic’s Paceart Optima, an on-premises cardiac workflow solution. The company said the acquisition will add nearly 1,000 clinic locations worldwide and boost its ability to provide a comprehensive cardiac remote monitoring solution.
 
PaceMate’s end-to-end platform supports cardiac device types including implantables, ambulatory monitors, heart failure devices, and remote patient monitors. This is supported by a suite of flexible solutions like software, patient communications, and clinical service support.
 
The flagship PaceMateLIVE is a remote cardiac monitoring software that uses electronic health record (EHR) integrations for seamless implementation, intuitive use, and intelligent patient prioritization, the company said.
 
“After a comprehensive evaluation, we are confident PaceMate is the best organization to service Paceart customers and their future cardiac data workflow needs,” said Kweli P. Thompson, MD, M.P.H., senior VP and president, Medtronic Cardiac Rhythm Management. “PaceMate offers best-in-class cardiac data management solutions and will provide excellent ongoing support to Paceart customers.”
 
“Our shared values, dedication to customer experience, and commitment to exceptional patient-centric cardiac solutions make this agreement a perfect fit,” added Tripp Higgins, CEO of PaceMate. “Paceart customers will benefit from the continued support of Paceart employees transitioning to PaceMate, as well as enhanced service delivery and innovation. We are excited to set a new standard in the market by combining the strengths of both technologies for unparalleled support and advancement.”